MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes
Authors:
- 31 August 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 308, 120925
Abstract
No abstract availableKeywords
Funding Information
- Department of Education of Zhejiang Province (Y202043471)
- National Natural Science Foundation of China (81770573)
- National Natural Science Foundation of China (81870400)
- National Natural Science Foundation of China (82070585)
This publication has 40 references indexed in Scilit:
- MicroRNA: Function, Detection, and BioanalysisChemical Reviews, 2013
- High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in ChinaJournal of Hepatology, 2013
- MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesisJournal of Clinical Investigation, 2012
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Oleuropein attenuates hepatic steatosis induced by high-fat diet in miceJournal of Hepatology, 2011
- Expression of islet-specific microRNAs during human pancreatic developmentGene Expression Patterns, 2009
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionHepatology, 2008
- A pancreatic islet-specific microRNA regulates insulin secretionNature, 2004
- PEROXISOMALβ-OXIDATION ANDPEROXISOMEPROLIFERATOR–ACTIVATEDRECEPTORα: An Adaptive Metabolic SystemAnnual Review of Nutrition, 2001
- Ratio‐fluorescence microscopy of lipid oxidation in living cells using C11‐BODIPY581/591FEBS Letters, 1999